The price paid for the common stock is equal to the consolidated closing bid price on the Nasdaq global market on the day of pricing, February 13, 2009.
The financing was led by Venrock with participation by Frazier Healthcare Ventures, Domain Associates, Versant Ventures, New Enterprise Associates, Bay City Capital and T Rowe Price Associates.